e-learning
resources
Berlin 2008
Monday, 06.10.2008
Interferon-gamma release assay tests for diagnosing tuberculosis infection and disease
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
A screening for latent tuberculosis infection among candidates to anti-tumor necrosis factor-alpha agents using a whole blood interferon-gamma test
G. Ferrara, M. Cicoletti, A. Galullo, C. Sabatini, I. Leli, P. Bruni, R. Mazzolla, M. Papini, S. Coaccioli, L. Casali (Terni, Perugia, Italy)
Source:
Annual Congress 2008 - Interferon-gamma release assay tests for diagnosing tuberculosis infection and disease
Session:
Interferon-gamma release assay tests for diagnosing tuberculosis infection and disease
Session type:
Thematic Poster Session
Number:
2521
Disease area:
Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
G. Ferrara, M. Cicoletti, A. Galullo, C. Sabatini, I. Leli, P. Bruni, R. Mazzolla, M. Papini, S. Coaccioli, L. Casali (Terni, Perugia, Italy). A screening for latent tuberculosis infection among candidates to anti-tumor necrosis factor-alpha agents using a whole blood interferon-gamma test. Eur Respir J 2008; 32: Suppl. 52, 2521
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Aetiopathogenesis, immunology and microbiology of tuberculosis
Evaluating 17 years of latent tuberculosis infection screening in north-west England: a retrospective cohort study of reactivation
Comparison of bronchodilator responsiveness in children with primary ciliary dyskinesia and cystic fibrosis
Related content which might interest you:
The levels of tumour necrosis factor-alpha and interleukin-1 in newly diagnosed and multi drug resistant tuberculosis
Source: Annual Congress 2004 - Clinical and diagnostic features of tuberculosis
Year: 2004
Isoniazid protection and risk of tuberculosis in patients who used anti tumor necrosis factor-alpha treatment
Source: Annual Congress 2007 - New perspectives and old problems in diagnosing tuberculosis infection and disease
Year: 2007
Implication of leptin, tumor necrosis factor-alpha, interleukin-1 and interleukin-6 in the pathogenesis of wasting in tuberculosis
Source: Annual Congress 2006 - Immunology of tuberculosis and diagnosis of tuberculosis infection
Year: 2006
Re-activation of bovine tuberculosis in a patient treated with infliximab
Source: Eur Respir J 2008; 32: 229-231
Year: 2008
Screening for latent tuberculosis before tumour necrosis factor antagonist therapy
Source: Eur Respir J 2015; 45: 1510-1512
Year: 2015
Screening for latent tuberculosis before tumour necrosis factor antagonist therapy
Source: Eur Respir J 2015; 45: 1512-1513
Year: 2015
Evaluating the potential of IP-10 and MCP-2 as biomarkers for the diagnosis of tuberculosis
Source: Eur Respir J 2008; 32: 1607-1615
Year: 2008
Mycobacterial diseases developed during anti-tumour necrosis factor alpha therapy
Source: Eur Respir J 2014; 44: 1289-1295
Year: 2014
The risk of tuberculosis related to tumour necrosis factor antagonist therapies: a TBNET consensus statement
Source: Eur Respir J 2010; 36: 1185-1206
Year: 2010
QuantiFERON-TB Gold and the TST are both useful for latent tuberculosis infection screening in autoimmune diseases
Source: Eur Respir J 2009; 33: 586-593
Year: 2009
Use of tuberculin skin test, IFN-gamma release assays and IFN-gamma-induced protein-10 to identify children with TB infection
Source: Eur Respir J 2013; 41: 644-648
Year: 2013
Tumor necrosis factor alpha inhibitors and reactivation of tuberculosis
Source: Eur Respir J 2007; 30: Suppl. 51, 281s
Year: 2007
Changes in the quantity of 1b-interleukin (IL-1b), tumor necrosis factor-a (TNF-a) and interferon-g (IF-g) in evaluation of the effectiveness of treatment of tuberculosis by DOTS
Source: Eur Respir J 2004; 24: Suppl. 48, 486s
Year: 2004
Screening and monitoring of tuberculosis in patients on tumor necrosis factor antagonist therapy
Source: Annual Congress 2011 - Clinical challenges in tuberculosis
Year: 2011
Using an interferon-γ assay for the diagnosis of tuberculosis infection before using tumor necrosis factor-α blockers
Source: Annual Congress 2007 - Gamma-interferon-based tests to diagnose tuberculosis infection and disease
Year: 2007
Mould exposure at home relates to inflammatory markers in blood
Source: Eur Respir J 2003; 21: 317-322
Year: 2003
Evaluation levels of pro-inflammatory cytokines tumour necrosis factor (TNF)-alpha and interferon (IFN)-gamma in lung cancer complicated with metastatic pleurisy
Source: Eur Respir J 2001; 18: Suppl. 33, 233s
Year: 2001
Serial interferon-gamma release assays for screening and monitoring of tuberculosis infection during treatment with biologic agents
Source: Annual Congress 2013 –Tuberculosis and latent tuberculosis infection in subpopulations
Year: 2013
Update: T-cell interferon-gamma release assays for the diagnosis of MTB infection
Source: Annual Congress 2008 - PG20 - Advances in the diagnosis of Mycobacterium tuberculosis infection: an interactive, case-based course
Year: 2008
An evaluation of the use of a negative interferon gamma release assay for tuberculosis screening before TNF antagonist therapy
Source: Eur Respir J 2014; 44: 1369-1372
Year: 2014
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept